查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585654

生物製藥生物分離系統市場：按類型、最終用戶分類 - 全球預測 2025-2030 年

Biopharmaceutical Bioseparation Systems Market by Type (Cell Disruption Technology, Centrifuges Technology, Chromatography Technique), End-user (Biopharmaceutical Companies, Research Institutes) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年生物製藥生物分離系統市場價值為151億美元，預計到2024年將達到164.8億美元，複合年成長率為9.49%，到2030年達到284.9億美元。

生物製藥生物分離系統包括用於從生物基質中分離和精製生物分子（例如蛋白質、核酸和細胞）的多種技術和方法。這些系統對於生產高純度生物藥品和確保治療的安全性、有效性和品質至關重要。對生技藥品、個人化醫療和基因療法不斷成長的需求強調了對這些系統的需求。生物分離系統應用於各種過程，例如過濾、離心、層析法和電泳。最終用途範圍涵蓋生物製藥製造、學術研究和臨床診斷等產業。主要成長動力包括生物技術的進步、生技藥品研發投資的增加以及嚴格的純度和品質監管標準。慢性病發病率的增加和對高效治療藥物的需求進一步推動了市場的擴張。

主要市場統計
基準年[2023] 151億美元
預測年份 [2024] 164.8億美元
預測年份 [2030] 284.9億美元
複合年成長率（%） 9.49%

市場洞察揭示了開發高容量、經濟高效且環境永續的生物分離系統的潛在機會。公司可以透過投資自動化數位化來提高流程效率和資料整合能力來實現成長。然而，高營運成本、技術複雜性和監管合規障礙等挑戰可能會阻礙成長。供應鏈中斷和缺乏熟練的專業人員也是主要障礙。為了克服這些障礙，該行業可以探索知識交流和能力建設的夥伴關係和協作。一次性技術、連續處理以及將人工智慧和機器學習整合到生物分離中的創新提供了有前景的成長領域。此外，解決生產中的可擴展性問題將培養未來的市場潛力。市場的動態特徵是快速的技術進步和不斷變化的消費者需求，需要在產品開拓和經營模式方面採取敏捷的策略和積極的創新。隨著個人化醫療變得越來越普遍，專注於小規模、靈活的生物分離解決方案可能為尋求佔領新興細分市場的公司提供利潤豐厚的機會。

市場動態：快速發展的生物製藥生物分離系統市場的關鍵市場洞察

供需的動態交互作用正在改變生物製藥生物分離系統市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 對生物製藥和個人化藥物的需求不斷增加
    • 政府支持國內醫藥產業的舉措
    • 標靶治療的日益普及和重要性
  • 市場限制因素
    • 生物分離設備初始投資及營運成本較高
  • 市場機會
    • 增加對生物分離公司和技術的投資
    • 生物製藥分離技術不斷進步
  • 市場挑戰
    • 監管挑戰和複雜的檢驗流程

波特五力：駕馭生物製藥生物分離系統市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解生物製藥生物分離系統市場的外部影響

外部宏觀環境因素在塑造生物製藥生物分離系統市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析了解生物製藥生物分離系統市場的競爭格局

生物製藥生物分離系統市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣生物製藥生物分離系統市場供應商的績效評估

FPNV定位矩陣是評估生物製藥生物分離系統市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃生物製藥生物分離系統市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對生物製藥生物分離系統市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對生物製藥和個人化藥物的需求增加
      • 政府支持國內醫藥產業的舉措
      • 標靶治療的日益普及和重要性
    • 抑制因素
      • 生物分離設備的初期投資和運作成本較高。
    • 機會
      • 增加對生物分離公司和技術的投資
      • 生物製藥分離技術的進展
    • 任務
      • 監管挑戰和複雜的檢驗流程
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章生物製藥生物分離系統市場：依類型

  • 細胞破壞技術
  • 離心機技術
  • 層析法技術
  • 電泳
  • 萃取技術
  • 過濾技術
  • 基於膜的
  • 沉澱

第7章生物製藥生物分離系統市場：依最終用戶分類

  • 生物製藥公司
  • 調查機構

第8章北美和南美生物製藥生物分離系統市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太生物製藥生物分離系統市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲/中東/非洲生物製藥生物分離系統市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 3M Company
  • Agilent Technologies, Inc.
  • Alfa Wassermann, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Astrea Bioseparations Limited
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Flottweg SE
  • GEA Group Aktiengesellschaft
  • GL Sciences Inc.
  • Hitachi High-Tech Corporation.
  • Jasco Pty Ltd.
  • KNAUER Wissenschaftliche Gerate GmbH
  • Merck KGaA
  • Novasep Holding SAS
  • PerkinElmer Inc.
  • Repligen Corporation
  • Restek Corporation
  • Sartorius AG
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.
  • Tosoh Bioscience LLC
  • Waters Corporation
  • YMC Co., Ltd.
Product Code: MRR-521BAA36EA6F

The Biopharmaceutical Bioseparation Systems Market was valued at USD 15.10 billion in 2023, expected to reach USD 16.48 billion in 2024, and is projected to grow at a CAGR of 9.49%, to USD 28.49 billion by 2030.

Biopharmaceutical bioseparation systems encompass a range of technologies and methodologies used to isolate and purify biomolecules such as proteins, nucleic acids, and cells from biological matrices. These systems are critical in producing high-purity biopharmaceuticals, ensuring the safety, efficacy, and quality of therapeutic products. The necessity of these systems is underscored by the growing demand for biologics, personalized medicine, and gene therapies. Bioseparation systems are applied in various processes including filtration, centrifugation, chromatography, and electrophoresis. The end-use scope spans industries such as biopharmaceutical manufacturing, academic research, and clinical diagnostics. Key growth drivers include advancements in biotech, increasing investment in biologics R&D, and stringent regulatory standards for purity and quality. The rise in chronic diseases and demand for efficient therapeutics further fuels market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 15.10 billion
Estimated Year [2024] USD 16.48 billion
Forecast Year [2030] USD 28.49 billion
CAGR (%) 9.49%

Market insights reveal potential opportunities in developing high-capacity, cost-effective, and environmentally sustainable bioseparation systems. Companies can seize growth by investing in automation and digitalization, enhancing process efficiency and data integration capabilities. However, challenges such as high operational costs, technical complexities, and regulatory compliance hurdles may impede growth. Supply chain disruptions and a shortage of skilled professionals also present significant obstacles. To overcome these barriers, the industry can explore partnerships and collaborations for knowledge exchange and capacity building. Innovations in single-use technologies, continuous processing, and integration of AI and machine learning into bioseparation offer promising areas for growth. Furthermore, addressing scalability issues in production can drive future market potential. The market's dynamic nature is characterized by rapid technological advancements and shifting consumer demands, necessitating agile strategies and proactive innovation in product development and business models. As personalized medicine gains traction, focusing on smaller-scale, flexible bioseparation solutions may present lucrative opportunities for businesses aiming to capture emerging segments.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biopharmaceutical Bioseparation Systems Market

The Biopharmaceutical Bioseparation Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing demand for biopharmaceuticals and personalized medicines
    • Government initiatives to boost domestic pharmaceutical industry
    • Growing popularity and importance of targeted therapies
  • Market Restraints
    • High initial investments and operating costs of bioseparation equipment
  • Market Opportunities
    • Growing investments in bioseparation companies and technologies
    • Rising advancements in biopharmaceutical separation technologies
  • Market Challenges
    • Regulatory challenges and complex validation processes

Porter's Five Forces: A Strategic Tool for Navigating the Biopharmaceutical Bioseparation Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biopharmaceutical Bioseparation Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biopharmaceutical Bioseparation Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biopharmaceutical Bioseparation Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biopharmaceutical Bioseparation Systems Market

A detailed market share analysis in the Biopharmaceutical Bioseparation Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biopharmaceutical Bioseparation Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biopharmaceutical Bioseparation Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biopharmaceutical Bioseparation Systems Market

A strategic analysis of the Biopharmaceutical Bioseparation Systems Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceutical Bioseparation Systems Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Agilent Technologies, Inc., Alfa Wassermann, Inc., Asahi Kasei Medical Co., Ltd., Astrea Bioseparations Limited, Bio-Rad Laboratories, Inc., Danaher Corporation, Flottweg SE, GEA Group Aktiengesellschaft, GL Sciences Inc., Hitachi High-Tech Corporation., Jasco Pty Ltd., KNAUER Wissenschaftliche Gerate GmbH, Merck KGaA, Novasep Holding SAS, PerkinElmer Inc., Repligen Corporation, Restek Corporation, Sartorius AG, Shimadzu Corporation, Thermo Fisher Scientific Inc., Tosoh Bioscience LLC, Waters Corporation, and YMC Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Biopharmaceutical Bioseparation Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Cell Disruption Technology, Centrifuges Technology, Chromatography Technique, Electrophoresis, Extraction Technique, Filtration Technology, Membrane-based, and Precipitation.
  • Based on End-user, market is studied across Biopharmaceutical Companies and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for biopharmaceuticals and personalized medicines
      • 5.1.1.2. Government initiatives to boost domestic pharmaceutical industry
      • 5.1.1.3. Growing popularity and importance of targeted therapies
    • 5.1.2. Restraints
      • 5.1.2.1. High initial investments and operating costs of bioseparation equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing investments in bioseparation companies and technologies
      • 5.1.3.2. Rising advancements in biopharmaceutical separation technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory challenges and complex validation processes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biopharmaceutical Bioseparation Systems Market, by Type

  • 6.1. Introduction
  • 6.2. Cell Disruption Technology
  • 6.3. Centrifuges Technology
  • 6.4. Chromatography Technique
  • 6.5. Electrophoresis
  • 6.6. Extraction Technique
  • 6.7. Filtration Technology
  • 6.8. Membrane-based
  • 6.9. Precipitation

7. Biopharmaceutical Bioseparation Systems Market, by End-user

  • 7.1. Introduction
  • 7.2. Biopharmaceutical Companies
  • 7.3. Research Institutes

8. Americas Biopharmaceutical Bioseparation Systems Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biopharmaceutical Bioseparation Systems Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biopharmaceutical Bioseparation Systems Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Agilent Technologies, Inc.
  • 3. Alfa Wassermann, Inc.
  • 4. Asahi Kasei Medical Co., Ltd.
  • 5. Astrea Bioseparations Limited
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Danaher Corporation
  • 8. Flottweg SE
  • 9. GEA Group Aktiengesellschaft
  • 10. GL Sciences Inc.
  • 11. Hitachi High-Tech Corporation.
  • 12. Jasco Pty Ltd.
  • 13. KNAUER Wissenschaftliche Gerate GmbH
  • 14. Merck KGaA
  • 15. Novasep Holding SAS
  • 16. PerkinElmer Inc.
  • 17. Repligen Corporation
  • 18. Restek Corporation
  • 19. Sartorius AG
  • 20. Shimadzu Corporation
  • 21. Thermo Fisher Scientific Inc.
  • 22. Tosoh Bioscience LLC
  • 23. Waters Corporation
  • 24. YMC Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CELL DISRUPTION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGES TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY EXTRACTION TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY FILTRATION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 106. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023